Malignant Gastric Neoplasm — Trials

Malignant Gastric Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 652
Recruiting: 352
Ph III recruiting: 49
Growth YoY: +15.1%
Industry share: 26%
Top sponsor: Fudan University
Termination share: 26.2%
Trials / 1,000 deaths: 59.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (232)

clinicaltrialsPublishedShowing 301–342 of 342 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00012363	S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus	completed	Phase 2	61	SWOG Cancer Research NetworkNETWORK	1	Jun 14, 2012	clinicaltrials
NCT00004895	Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery	completed	Phase 2	—	Northwestern UniversityOTHER	1	Jun 6, 2012	clinicaltrials